Avantor PE Ratio 2018-2025 | AVTR

Current and historical p/e ratio for Avantor (AVTR) from 2018 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Avantor PE ratio as of June 10, 2025 is 13.55.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Avantor PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-06-11 13.52 13.00
2025-03-31 16.21 $1.04 15.59
2024-12-31 21.07 $1.04 20.26
2024-09-30 25.87 $0.46 56.24
2024-06-30 21.20 $0.54 39.26
2024-03-31 25.57 $0.39 65.56
2023-12-31 22.83 $0.48 47.56
2023-09-30 21.08 $0.54 39.04
2023-06-30 20.54 $0.63 32.60
2023-03-31 21.14 $0.92 22.98
2022-12-31 21.09 $1.02 20.68
2022-09-30 19.60 $0.94 20.85
2022-06-30 31.10 $0.93 33.44
2022-03-31 33.82 $0.89 38.00
2021-12-31 42.14 $0.86 49.00
2021-09-30 40.90 $0.79 51.77
2021-06-30 35.51 $0.45 78.91
2021-03-31 28.93 $0.29 99.76
2020-12-31 28.15 $0.09 312.78
2020-09-30 22.49 $0.12 187.42
2020-06-30 17.00 $0.23 73.91
2020-03-31 12.49 $-0.83 0.00
Sector Industry Market Cap Revenue
Medical Medical Services $9.329B $6.784B
Avantor Inc. is a provider of critical products and services primarily to biopharma, healthcare, education & government, advanced technologies & applied materials industries. Avantor Inc. is based in Radnor, United States.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $145.009B 27.20
Elevance Health (ELV) United States $86.741B 11.19
CVS Health (CVS) United States $81.290B 10.10
Cencora (COR) United States $55.092B 19.17
DiDi Global (DIDIY) China $23.485B 35.64
Natera (NTRA) United States $22.560B 0.00
BioMerieux (BMXMF) France $16.856B 0.00
Solventum (SOLV) United States $13.071B 13.84
EUROFINS SCIENT (ERFSF) Luxembourg $13.026B 0.00
ICON (ICLR) Ireland $11.688B 10.87
Revvity (RVTY) United States $11.345B 19.52
CochLear (CHEOY) Australia $11.134B 0.00
Doximity (DOCS) United States $10.995B 50.90
Viatris (VTRS) United States $10.610B 3.65
HealthEquity (HQY) United States $9.272B 40.61
Medpace Holdings (MEDP) United States $8.792B 23.35
Sonic Healthcare (SKHHY) Australia $8.450B 0.00
Charles River Laboratories (CRL) United States $7.416B 14.53
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.450B 26.21
BrightSpring Health Services (BTSG) United States $3.875B 35.87
Sotera Health (SHC) United States $3.491B 19.84
Surgery Partners (SGRY) United States $2.989B 38.87
Alignment Healthcare (ALHC) United States $2.898B 0.00
Concentras Parent (CON) United States $2.816B 16.27
Organon (OGN) United States $2.610B 2.77
GeneDx Holdings (WGS) United States $1.983B 76.39
Progyny (PGNY) United States $1.923B 42.32
Ardent Health Partners (ARDT) United States $1.920B 8.18
Premier (PINC) United States $1.884B 14.30
PACS (PACS) United States $1.629B 0.00
GoodRx Holdings (GDRX) United States $1.622B 32.43
Teladoc Health (TDOC) United States $1.298B 0.00
Pediatrix Medical (MD) United States $1.213B 9.23
Establishment Labs Holdings (ESTA) $1.124B 0.00
CareDx (CDNA) United States $1.105B 17.26
Ryman Healthcare (RYHTY) New Zealand $1.011B 0.00
Agilon Health (AGL) United States $0.944B 0.00
AMN Healthcare Services Inc (AMN) United States $0.843B 7.89
QDM (QDMI) Hong Kong, SAR China $0.752B 0.00
Nutex Health (NUTX) United States $0.651B 9.85
Embecta (EMBC) United States $0.592B 3.99
LifeMD (LFMD) United States $0.553B 0.00
Enhabit (EHAB) United States $0.543B 44.67
InnovAge Holding (INNV) United States $0.514B 0.00
SBC Medicals (SBC) United States $0.495B 0.00
Sonida Senior Living (SNDA) United States $0.474B 0.00
Auna S.A (AUNA) Luxembourg $0.470B 10.58
COMPASS Pathways (CMPS) United Kingdom $0.445B 0.00
Performant Healthcare (PHLT) United States $0.258B 0.00
Oncology Institute (TOI) United States $0.237B 0.00
Beauty Health (SKIN) United States $0.202B 0.00
DocGo (DCGO) United States $0.156B 25.50
KindlyMD (KDLY) United States $0.150B 0.00
Pheton Holdings (PTHL) China $0.104B 0.00
So-Young (SY) China $0.090B 0.00
OncoCyte (OCX) United States $0.079B 0.00
Basel Medical Group (BMGL) Singapore $0.075B 0.00
KindlyMD (NAKA) United States $0.070B 0.00
Ascend Wellness Holdings (AAWH) United States $0.060B 0.00
NeueHealth (NEUE) United States $0.060B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
Sera Prognostics (SERA) United States $0.056B 0.00
Biodesix (BDSX) United States $0.048B 0.00
ModivCare (MODV) United States $0.047B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.029B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00